Navigation Links
High-Throughput Isolation of Total RNA


Rapidly isolate total RNA from 96 samples

Karen Dolter Sylvia Norman Jeff Braman
Stratagene

The StrataPrep 96 total RNA purification kit provides a convenient method for simultaneous isolation of total RNA from up to 96 cultured cell samples. Because RNA is bound to a solid support, there is no need for organic extraction and alcohol precipitation. The resulting RNA is high quality, with no detectable DNA contamination, and is ready for molecular beacon and conventional RT-PCR applications.

Isolating total RNA from many samples by traditional methods can be time-consuming and tedious. The StrataPrep method is efficient and allows processing of a wide range of sample sizes, from 10 cells to 5 x 105 cells per well.

Protocol

Fig.1

An overview of the StrataPrep 96 protocol is shown in Figure 1. After cultured cells are disrupted by guanidine thiocyanate, lysates are applied to a silica-based fiber matrix within the 96-well plate. RNA is immobilized on the fiber matrix, and contaminants are removed while avoiding organic extractions and ethanol precipitation. The sample is treated with DNase directly on the fiber matrix and pure RNA is recovered by eluting with a small volume of buffer.

The standard protocol makes use of a vacuum manifold and a tabletop centrifuge. If a vacuum manifold is not available, an alternate protocol, which uses the centrifuge alone, may be used (additional materials required).

Isolation of RNA from Various Cell Lines

* Numbers in parenthesis indicate the number of isolations performed.

Species

Cell line

5 x 105 cells

2 x 105 cells

1 x 105 cells

Mouse

NIH/3T3

11.0 (4)*

4.1 (4)

2.9 (4)

Hamster

CHO

4.7 (60)

Human

HeLa

9.2 (3)

5.5 (1)

2.1 (3)

Human

HL-60

4.0 (3)

1.9 (3)

1.1 (3)

Human

THP-1

6.4 (1)

1.6 (1)

0.8 (1)

Table 1 and Table 2 show total RNA yields from different cell numbers of a variety of cell lines. A typical mammalian cell contains approximately 10-5 g of total RNA.1 The yields for all cell lines are close to or higher than this number, indicating high yields. The A260/A280 ratios measured for samples isolated from 1 x 105 to 5 x 105 cells is greater than 1.9 for all samples, indicating high-quality RNA. Samples isolated from 1 x 101 to 1 x 104 cells (Table 2) were quantitated in fluorescent assays using the RiboGreen RNA quantitation kit (Molecular Probes) since absorbance measurements cannot be taken for such small samples. These samples also reflect yields of approximately 10-5 g of total RNA per cell.

* RNA was quantitated by the RiboGreen assay using dilutions of an rRNA standard.

Numbers in parentheses indicate the number of isolations performed.

Cell line

104 cells

103 cells

102 cells

101 cells

HeLa

119 (6)

9.6 (6)

1.0 (6)

0.211 (2)

HL-60

53 (1)

4.8 (1)

0.53 (1)

THP-1

84 (1)

6.9 (1)

0.97 (1)

0.110 (1)

NIH/3T3

325 (4)

23.3 (4)

2.9 (4)

Representative RNAs (Table 1) were electrophoresed in formaldehyde-agarose gels to check the integrity of the RNA. All of the samples are intact according to this analysis, as observed by the distinct rRNA bands (Figure 2).

Fig.2

RT-PCR Analysis of RNA from HeLa Cells

Total RNA isolated from various numbers of HeLa cells was tested as a template in RT-PCR. Amplification using the human GAPDH primer set for RT-PCR with the prostar Ultra HF RT-PCR system4 was successful with all samples, including RNA isolated from only 10 cells (Figure 3). The absence of bands for negative control reactions shows that the PCR reactions are not contaminated with the target sequence.

Fig.3

Detecting Low-Abundance RNA Using Molecular Beacon RT-PCR

RNA from varying numbers of HeLa cells was also subjected to molecular beacon RT-PCR analysis5 using primers and a beacon specific for the low-abundance target HPRT (Figure 4). The beacon hybridizes quantitatively to the target sequence and emits fluorescence in this conformation. The threshold cycle number (Ct) is inversely proportional to the concentration of target sequence in the reaction.6 This low-abundance target was readily detected from an RNA sample isolated from as few as 10 cells (Ct=35).

Fig.4

Comparison of 96-Well Total RNA Isolation Kits

DNA contamination of RNA samples can interfere with RT-PCR since DNA may serve as a template during PCR. Therefore, it is imperative to remove DNA during RNA isolation. Total RNA was isolated from NIH/3T3 cells grown in 96-well plates using the StrataPrep 96 total RNA purification kit and the RNeasy 96 total RNA isolation kit from Qiagen. RNA isolations were performed according to each kits instructions. The RNeasy 96 kit does not include DNase but does make available a supplemental protocol for DNase treatment; hence, we were able to carry out an RNA isolation with as well as without DNase treatment.

The StrataPrep 96 kit, with DNase treatment, generated RNA yields similar to the RNeasy 96 kit without DNase treatment (Table 3). When DNase treatment was included with the RNeasy 96 protocol, RNA yields decreased. The StrataPrep 96 kit samples have the highest RNA concentrations, which is especially important for analyzing small samples.

* RNA was isolated from NIH/3T3 cells grown in 96-well plates (approximately 3.8 x 104 cells/well). The numbers are averages of three samples containing four pooled samples each. Yields were determined by spectrophotometric analysis.

The alternate protocol for the StrataPrep 96 kit was also tested (additional materials required).

Yield (g/well)

Concentration (g/ml)

A260/A280

StrataPrep kit

1.0 0.02

40 1.0

2.0 0.02

StrataPrep, spin only

0.9 0.07

48 2.0

2.1 0.04

RNeasy 96

1.0 0.22

16 2.3

1.9 0.05

RNeasy 96 + DNase

0.6 0.13

8 1.9

1.9 0.07

RT-PCR was performed on RNA samples isolated with both kits using primers specific for GAPDH. These primers amplify a 209-bp product from cDNA and from pseudogene sequences in genomic DNA. We performed cDNA synthesis reactions both in the presence and absence of reverse transcriptase, followed by PCR as an assay for DNA contamination. No DNA was detected in the StrataPrep 96 kit samples using either the standard or the alternate protocol, whereas both of the RNeasy 96 samples demonstrated DNA contamination, even when DNase treatment was included (Figure 5).

Fig.5

Conclusions

The StrataPrep 96 total RNA purification kit is the method of choice for isolating RNA from as many as 96 cultured cell samples. The method generates pure, intact RNA with high yields. While amplification by conventional and molecular beacon RT-PCR can be achieved for samples isolated from as few as 10 cells, the StrataPrep 96-well RNA kit is clearly superior when compared with the RNeasy kit because Stratagenes kit yields RNA at a higher concentration with no detectable DNA contamination.

Acknowledgments

The authors thank Gothami Padmabandu and Reinhold Mueller for performing molecular beacon RT-PCR.

REFERENCES

  1. Sambrook, J., et al. (1989) Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.

  2. Steege, M. and Cayouette, M. (1996) Strategies 9: 53-56.

  3. Cayouette, M. and Hansen, C. (1996) Strategies 9: 56-57.

  4. Borns, M. et al. (1999) Strategies 12: 33-36.

  5. Padmabandu, G. and Mueller, R. (1999) Strategies 12: 94-97.

  6. Cayouette, M., et al. (1999) Strategies 12: 85-88.


'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
2. Highest Possible Transformation Efficiencies for High-Throughput Applications
3. High-Throughput Cultivation of Bacterial Clones
4. High-Throughput System Generates Ultra-Pure PCR Products Suitable for All Applications
5. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
6. Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A
7. Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood
8. Simple Isolation of RNA from Tissue and Cultured Cells
9. Fast Isolation of Total RNA from Small Numbers of Cells
10. Comparison of Growth Techniques and Media for the Purpose of Plasmid Isolation from E. coli Using the Eppendorf Perfectprep Plasmid Mini Kit
11. Isolation of Microorganisms

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High Throughput Isolation Total RNA

(Date:12/2/2009)... , NEW YORK, Dec. 2 Repor...eport is available in its catalogue: ,, Carbon...,, http://www.reportlinker.com/p0164368/Carbon...tml ,, Incubators are the most critical equip...rch, and other applications for providing a contro...
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/...ompany") (TSX:ONC; NASDAQ: ONCY ) announced today ...nit offering, the underwriters have exercised in f...dditional 637,500 units. Each unit is comprised of...se warrant, and was sold at a price of US$3.00 per...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BIO... novel oral JAK2 inhibitor, SB1518, at The America...position in New Orleans. ,, Data will be presen...escalation trial of SB1518 detailing its safety, t...K/PD) profile in dose levels ranging from 100 to 6...
(Date:12/2/2009)... The Scientist, a leading scient...hotometrics’ Evolve “Intelligent&rdquo...s “Top 10 Innovations of 2009. , ...lve ™ EMCCD camera from Photometrics ®...CCD and EMCCD cameras for the life sciences, was r...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...., Feb. 3 Genomic Health,Inc. (Nasdaq: GHDX ) t...ess for,the fourth quarter and year ended December...ter of 2008 increased to $31.2 million,compared wi...roduct revenue,from the Oncotype DX(R) breast canc...f 2008, an increase of 60 percent, compared with $...
...Newswire-FirstCall/ - Victhom Human Bionics Inc., ...obionix division has obtained CE Mark approval for... for a closed-loop system (CLS) used on peripheral...eded for the sale of the Neurostep(TM) in any of t...ostep(TM), a fully implantable investigational neu...
...hite Paper Reports More Than 75% of Biotech Firms ...ship in Next Three Years , , NEW YORK, Feb. 3 Mo...plore business partnerships and strategic alliance...ding to "Plumbing the Depths," a new white paper r... www.rkco.com ). Results were based on the finding...
Other Biology Technology:Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 2Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 3Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 4Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 5Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 6Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 7Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 8Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 9Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop 2Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop 3Volatile Economy / Fundraising Challenges Encourage Business Combinations Among Biotech Companies According to New Survey from CPA Firm Rothstein Kass 2Volatile Economy / Fundraising Challenges Encourage Business Combinations Among Biotech Companies According to New Survey from CPA Firm Rothstein Kass 3Volatile Economy / Fundraising Challenges Encourage Business Combinations Among Biotech Companies According to New Survey from CPA Firm Rothstein Kass 4
(Date:12/3/2009)...LADELPHIA Now in its 32nd year, the CTRC-AACR San...act the best in breast cancer science and world le...eradicating breast cancer. , This year, more th...ather at the Henry B. Gonzales Convention Center i...is a partnership between the American Association ...
(Date:12/3/2009)...est dwellers must be included in the design of the...oid a humanitarian crisis, according to a scientis...n Nature , Dr Simon Lewis argues that at least 50...penhagen, known as REDD (Reducing Emissions from D...orest dwellers directly, and their property rights...
(Date:12/2/2009)...HILADELPHIA Children exposed to secondhand cigare...g cancer in adulthood, even if they never smoked. ...r Epidemiology, Biomarkers & Prevention , a journa... as part of a special tobacco focus in the Decembe...mericans will be diagnosed with lung cancer; more ...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Over 60 Firms Confirmed to Attend CBIs Third Annual Bio Pharmaceutical Collaboration and Transaction Accounting Conference in September 13715 1Over 60 Firms Confirmed to Attend CBIs Third Annual Bio Pharmaceutical Collaboration and Transaction Accounting Conference in September 13715 2Memorial Blood Centers in Urgent Need of Type O Negative and Type B Negative Blood Donors 55487 1Memorial Blood Centers in Urgent Need of Type O Negative and Type B Negative Blood Donors 55487 2ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 1ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 2ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 4905 3
...nstitute have discovered that a protein known as F...rts of the body may have a function in the regulat...cate tissues that cannot survive the "inflammation...hat this discovery may ultimately help in the deve...h as macular degeneration and autoimmune diseases ...
... Department of Energy,s Pacific Northwest National...e machinery of life -- bringing us one step closer...he environment and protecting the country against ...ed "sequence alignment tool" that can divide the w...ragments so large data sets can run on many proces...
...ity genes by screening the genome of Caenorhabditi...ganism in genetics studies. The findings are repor...h of the 23 genes somehow normally acts to reduce ...eases lifespan. For example, the worm,s lifespan d...operly, and inhibition of another gene increases t...
Other Biology News:A protein in the eye may prevent immune response and protect eyes from disease 2Genomic sequences processed in minutes, rather than weeks 2
GR4 Auto Access 100V/50-60Hz from Thermo Scientific
...UF040A is a diluent that is designed for use with ...ies which are paired with a mouse monoclonal coati...d mouse proteins to prevent non-specific binding b...ll; This buffer may be used to stabilize newly c...
EZ-Tn5 Transposase from EPICENTRE Biotechnologies
...BL's bioassays for interferons are cytopathic effe...ral assays. Sample types include; tissue culture ...ormulations. In these assays, one unit is defined...iter to reduce the cytopathic effect of viral infe...
Biology Products: